49739-36-8Relevant articles and documents
NO-Donor Dihydroartemisinin Derivatives as Multitarget Agents for the Treatment of Cerebral Malaria
Bertinaria, Massimo,Orjuela-Sanchez, Pamela,Marini, Elisabetta,Guglielmo, Stefano,Hofer, Anthony,Martins, Yuri C.,Zanini, Graziela M.,Frangos, John A.,Gasco, Alberto,Fruttero, Roberta,Carvalho, Leonardo J. M.
, p. 7895 - 7899 (2015)
Hybrid products in which the dihydroartemisinin scaffold is combined with NO-donor furoxan and NONOate moieties have been synthesized and studied as potential tools for the treatment of cerebral malaria (CM). The designed products were able to dilate rat
4-Methyl-3-(arylsulfonyl)furoxans: A New Class of Potent Inhibitors of Platelet Aggregation
Calvino, R.,Fruttero, R.,Ghigo, D.,Bosia, A.,Pescarmona, G. P.,Gasco, A.
, p. 3296 - 3300 (2007/10/02)
A series of 4-methyl-3-(arylthio)furoxans were synthesized by oxidation of 1-(arylthio)-2-methylglyoxymes with dinitrogen tetroxide.Reduction with trimethyl phosphite of the furoxan derivatives afforded the corresponding furazans, while oxidation with an
Unsymmetrically substituted furoxans. III. Methylnitrofuroxan: its structure and behavior toward nucleophilic substitution
Gasco,Mortarini,Rua,Serafino
, p. 587 - 590 (2007/10/08)
-
